article thumbnail

India’s contract manufacturing gains momentum due to high quality & cost effectiveness: Expert

AuroBlog - Aurous Healthcare Clinical Trials blog

India is strengthening its scope in contract manufacturing as the global customers commend the strengths and dependability of its pharma and biotech sectors.

article thumbnail

Inflationary pressure causes drop-off in contract manufacturing M&A

Pharmaceutical Technology

As several economies deal with inflation, there has been a reduction in deals involving contract manufacturing organisations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

High interest rates will reduce investment in pharma contract manufacturers

Pharmaceutical Technology

During a time when increasingly innovative biologics are being approved and pharma companies are seeking contractors to mitigate the risk of supply chain disruptions, the long-term effects of slowing investment could significantly hinder global pharma manufacturing.

article thumbnail

How PartnerSlate is Digitizing the Food and Beverage Contract Manufacturing Industry

XTalks

The online marketplace PartnerSlate has made waves in the food and beverage contract manufacturing industry, recently securing a $4 million investment to further its mission of connecting food brands and contract manufacturers. This is where San Francisco-based PartnerSlate comes in.

article thumbnail

Distributed Control System Facilitates Expansion for New Drugs Produced by Contract Manufacturing Organization

Pharma Mirror

Combatting the pandemic has highlighted the importance of the partnership between biopharma organizations and the contract manufacturing organizations (CMOs) that must flexibly handle outsourced production, which can come suddenly and often must quickly be ramped up.

article thumbnail

Emergent to lay off around 400 in pivot away from contract manufacturing

Bio Pharma Dive

The job cuts will affect “all areas of the company” and, combined with other cost-reduction efforts, lead to annualized savings of over $100 million, Emergent said.

article thumbnail

Biologics Contract Manufacturing – Current Interest of the Pharmaceutical Industry

Roots Analysis

Although biopharmaceuticals offer significant profit margins and have demonstrated the potential to treat a myriad of disease indications, they are generally associated with high costs of development and complex manufacturing protocols. Advanced and complex technologies are required for manufacturing, as well as testing of biopharmaceuticals.